Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro

This publication has 27 references indexed in Scilit:

• Consideration of the use of 17?-N,N-diethylcarbamoyl-4-methyl-4-aza-5-?-androstan-3-one (4MA), a 5?-reductase inhibitor, in prostate cancer therapy
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• 17β-Hydroxysteroid dehydrogenases in human breast tissues: purification and characterization of soluble enzymes and the distribution of particulate and soluble forms in adipose, non-adipose and tumour tissues
  Journal of Molecular Endocrinology, 1991
• Effects of low testosterone levels and of adrenal androgens on growth of prostate tumor models in nude mice
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• Prostate Long-Term Epithelial Cell Lines. Biological and Biochemical Features
  Annals of the New York Academy of Sciences, 1990
• A new approach to prostate cancer
  Journal of Pharmacy and Pharmacology, 1989
• The effect of 4MA, a potent inhibitor of 5 alpha‐reductase, on the growth of androgen‐responsive human genitourinary tumors grown in athymic nude mice
  The Prostate, 1987
• The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
  The Prostate, 1986
• In vitro responses of human prostate tumour cell lines to a range of antitumour agents
  International Journal of Cancer, 1983
• STEROIDS OF ADRENAL ORIGIN METABOLIZED BY HUMAN PROSTATIC TISSUE BOTH IN VIVO AND IN VITRO
  Journal of Endocrinology, 1974
• The culture of mature organs in a synthetic medium
  Experimental Cell Research, 1959